Mettler-Toledo InternationalFRA:MTO +1.93%92 ROC (Joel Greenblatt) % is 88.25% as of Mar. 2026, which is 5% below its 10-year median of 93.28. GuruFocus rates FRA:MTO with a GF Score™ of 92/100 and a GF Value™ of €1,239.97 (Fairly Valued). The stock has 1 warning sign investors should review. Among 213 Medical Diagnostics & Research companies, Mettler-Toledo International ranks better than 96.71% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Mettler-Toledo International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 88.25%.
The historical rank and industry rank for Mettler-Toledo International's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:MTO'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 75.86 Med: 93.28 Max: 117.4
Current: 116.42
During the past 13 years, Mettler-Toledo International's highest ROC (Joel Greenblatt) % was 117.40%. The lowest was 75.86%. And the median was 93.28%.
FRA:MTO's ROC (Joel Greenblatt) % is ranked better than 96.71% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.02
vs FRA:MTO: 116.42
Mettler-Toledo International (FRA:MTO) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mettler-Toledo International ROC (Joel Greenblatt) % Chart
FRA:MTO vs ILMN, DGX, LH: ROC (Joel Greenblatt) % Comparison
For the Diagnostics & Research subindustry, Mettler-Toledo International's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mettler-Toledo International ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Mettler-Toledo International's ROC (Joel Greenblatt) % falls into.
Mettler-Toledo International ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 88.25% mean?
Mettler-Toledo International (FRA:MTO) has a ROC (Joel Greenblatt) % of 88.25% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Mettler-Toledo International and its competitors. This is near median its historical median of 93.28. Over the past decade, Mettler-Toledo International's ROC (Joel Greenblatt) % has ranged from 75.86 to 117.40. According to the industry distribution chart, Mettler-Toledo International ranks #7 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 3.3%.
Is Mettler-Toledo International's ROC (Joel Greenblatt) % too high?
Mettler-Toledo International's current ROC (Joel Greenblatt) % of 88.25% is near median its 10-year median of 93.28. Over the past 10 years, this metric has ranged from a low of 75.86 to a high of 117.40. Based on the distribution chart, Mettler-Toledo International ranks #7 out of 213 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Mettler-Toledo International has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's ROC (Joel Greenblatt) % compare to ILMN and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #7 out of 213 companies for ROC (Joel Greenblatt) %. This places Mettler-Toledo International in the top 3% of its industry — outperforming the majority of peers. Historically, Mettler-Toledo International's own ROC (Joel Greenblatt) % has ranged from 75.86 to 117.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Mettler-Toledo International and its competitors. Mettler-Toledo International's current ROC (Joel Greenblatt) % is 88.25%, which is near median its own 10-year median of 93.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Based on GuruFocus' analysis, Mettler-Toledo International (FRA:MTO) is currently considered Fairly Valued. The stock's GF Value™ is €1,239.97, compared to a current price of €1,160.00 — trading 6.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 88.25%, which is near median its 10-year median of 93.28. Mettler-Toledo International's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current ROC (Joel Greenblatt) % is 88.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?
Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued.
The current stock price of €1,160.00 is trading 6.4% below its estimated GF Value™ of €1,239.97.
GuruFocus considers Mettler-Toledo International to be Fairly Valued.
Key valuation signals for FRA:MTO:
ROC (Joel Greenblatt) %: 88.25% (near median its 10-year median of 93.28)
GF Value™: €1,239.97 vs. price of €1,160.00 (6.4% below fair value)
No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
92GF Score
Get the complete analysis for FRA:MTO
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MTO has been successfully added to your 
